Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Surprise Inspections, And More, Coming Soon To The EU

This article was originally published in The Gray Sheet

Executive Summary

It will be years before the device and diagnostic regulations proposed last month by the European Commission take effect, but policymakers are pressing forward to implement select reforms, including surprise facility inspections, on an interim basis by early next year.

You may also be interested in...



EU “Trialogue” On Device Reforms Could Happen By Early Next Year

Representatives of the three segments of the European Union government, the Parliament, Council and Commission, may begin formal talks on final legislative language to reform device and diagnostics regulations at the end of this year or early next year, according to the outgoing Greek presidency of the Council.

Regulatory News In Brief

IMDRF releases three new proposed guidance documents. FDA is accepting comments on its plans to accept electronic submissions for device recalls. More regulatory news.

EU Parliament’s Public Health Committee Debates Device Reform Proposal

Members of the committee appeared split on the question of centralized pre-market authorization during an April 24 debate, but generally supported other proposals in a committee report issued earlier this month.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031694

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel